Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | ||
| Net Income | 4,177,860 | 4,636,510 |
| Depreciation Amortization | 1,184,360 | 697,490 |
| Other Working Capital | -866,010 | 503,740 |
| Other Operating Activity | 479,950 | -470,410 |
| Operating Cash Flow | $4,976,160 | $5,367,330 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -448,140 | -312,560 |
| Net Acquisitions | -2,621,300 | -170,000 |
| Other Investing Activity | -1,962,320 | -3,790 |
| Investing Cash Flow | $-5,031,760 | $-486,350 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 65,200 | -4,881,150 |
| Financing Cash Flow | $65,200 | $-4,881,150 |
| Beginning Cash Position | 30 | 200 |
| End Cash Position | 9,640 | 30 |
| Net Cash Flow | $9,600 | $-170 |
| Free Cash Flow | ||
| Operating Cash Flow | 4,976,160 | 5,367,330 |
| Free Cash Flow | 4,976,160 | 5,367,330 |